Litcius/Paper detail

Baloxavir-oseltamivir combination therapy inhibits the emergence of resistant substitutions in influenza A virus PA gene in a mouse model

Jihyun Park, Beomkyu Kim, Khristine Joy C. Antigua, Ju Hwan Jeong, Chang il Kim, Won-Suk Choi, Sol Oh, Chan Hyung Kim, Eung‐Gook Kim, Young Ki Choi, Yun Hee Baek, Min‐Suk Song

2021Antiviral Research30 citationsDOI

Topics & Concepts

OseltamivirVirologyCombination therapyVirusAmino acid substitutionDrug resistanceInfluenza A virusPopulationAntiviral therapyGeneBiologyPharmacologyMedicineMicrobiologyCoronavirus disease 2019 (COVID-19)Internal medicineGeneticsMutationInfectious disease (medical specialty)DiseaseChronic hepatitisEnvironmental healthInfluenza Virus Research StudiesRespiratory viral infections researchinterferon and immune responses
Baloxavir-oseltamivir combination therapy inhibits the emergence of resistant substitutions in influenza A virus PA gene in a mouse model | Litcius